Page 32 - Vol.37-No.1 issue

NEW APPOINTED

CORTEVA WELCOMES NEW SENIOR VICE MATTHEW MEISTER
PRESIDENT AND CHIEF TECHNOLOGY OFFICER APPOINTED EXECUTIVE
VP & CFO
Corteva Welcomes New Senior Vice President
and Chief Technology Off cer Sam Eathington JBT announced that
Corteva, Incannounced that Sam Eathington, Ph.D., Matthew Meister has
a highly experienced agricultural scientist with exten- been appointed Ex-
sive expertise in developing cutting-edge technology, ecutive Vice President
has begun his role as Senior Vice President and Chief and Chief Financial
Technology Officer, effective January 1, 2021. Report- Officer. Mr. Meister
ing to Chief Executive Officer James C. Collins, Jr., Eath- has served as Inter-
ington has responsibility for the Company’s industry-leading portfolio of im CFO of JBT since
products and technology and spearheading global agricultural innovation September 2020 and
and sustainability. Eathington joins Corteva from The Climate Corporation previously served as Vice President and
(part of Bayer Crop Science) where he was Chief Science Officer. He spent CFO for JBT Protein since 2019. His ap-
nearly two decades focused on quantitative traits and molecular breeding pointment is effective immediately.
at Monsanto. “I am delighted that Matt will be a per-
“We are excited to have Sam take over as the leader of our R&D organ- manent part of our executive leadership
ization,” Collins said. “Sam has a long history of driving commercially team,” said Brian Deck, JBT’s President
successful scientific innovation and his insights and experience will be a and CEO. “As interim CFO, he has been
tremendous advantage for Corteva. With Sam’s leadership and expertise, a great source of support and leadership
we will continue to launch transformative solutions that meet the evolving amid unprecedented challenges. Matt
needs of consumers and empower farmers to produce more, building on brings extensive experience in global
the success of recent key product launches while further diversifying our manufacturing and significant financial
portfolio across crops and geographies. At the same time, we will continue acumen to the CFO role. His depth of in-
to advance the efficiency and productivity of our R&D operations and deliv- dustry knowledge and significant finan-
er greater value for our shareholders.” Circle 45 on enquiry card cial and operational experience make
him the ideal person to continue to lead
our finance team as we grow the business
AGCARM APPOINTS NEW ANIMAL HEALTH and drive shareholder value.”
EXPERT
BRIAN DECK APPOINTED
The industry association for crop protection and ani- PRESIDENT & CHIEF
mal health manufacturers and distributors has appoint-
ed Jeff Howe as its technical manager. EXECUTIVE OFFICER
Jeff Howe replaces Jan Quay, after a seventeen-year
tenure, as Agcarm’s animal health expert. As well as tak- JBT announced
ing the lead on animal health issues, Jeff provides techni- that Brian Deck has
cal support on the company’s crop protection and rural been appointed
supplier portfolios. President and Chief
JEFF HOWE Executive Officer.
“Getting better outcomes for farmers, animals, and con-
sumers of food and fibre is a key driver for me. I am excited about the pos- He has also been
sibilities for new technologies to increase productivity, reduce greenhouse elected to the Board
gas emissions, minimise residues, and help in the fight against antimicrobial of Directors. Mr.
resistance. Deck has served as
“I look forward to working closely with government and industry stake- Interim President and CEO of JBT Cor-
poration since June 2020 and previously
holders to facilitate access to cutting edge products that will support a more served as the Company’s Chief Financial
sustainable and innovative sector, and Agcarm’s vision of healthy crops - Officer since 2014. His appointments are
healthy animals - healthy business,” says Howe. Circle 46 on enquiry card effective immediately.
‘’Since joining JBT in 2014, and par-
MERCK ANIMAL HEALTH NAMES DR. ticularly as Interim CEO over the last
several months, Brian has been instru-
CHRISTINE ROYAL AS ITS U.S. COMPANION mental in delivering strong financial and
operational results while ensuring both
ANIMAL AND EQUINE BUSINESS LEADER our employees’ safety and customers’
satisfaction,” said Alan Feldman, JBT’s
Merck Animal Health, known as MSD Animal Health out- Chairman. “Brian has a demonstrated
side the US and Canada, a division of Merck & Co., Inc., track record of respected leadership and
Kenilworth, N.J., USA (NYSE:MRK), is pleased to announce success over the past seven years as CFO
that Christine Royal, DVM, has been named the Associate Vice President, U.S. at JBT. During his tenure, JBT delivered
Companion Animal and Equine business unit, effective immediately. shareholder returns more than three
“Dr. Royal brings to her role a deep understanding of contemporary veter- times that of the Russell 2000 Index. Brian
inary practices and a strong passion for animals and their caretakers,” said played an instrumental role in the devel-
Scott Bormann, Senior Vice President, North America, Merck Animal Health. opment of JBT’s strategy, enhanced the
“She has played an instrumental role in leading our company’s efforts to pro- portfolio with more than $1 billion of cap-
mote stronger animal welfare practices, and to bring increased awareness to ital deployment with the completion of 16
the mental health and wellbeing issues faced by the veterinarian profession. acquisitions, and played a key leadership
We look forward to her continued leadership, both within our organization role in the Company’s margin enhance-
and throughout the animal health industry.” ment efforts. Circle 48 on enquiry card
Circle 47 on enquiry card

30 Vol. 37 No. 1